Study of FOXO3a and the development of tamoxifen resistance in breast cancer

被引：0
|
作者：
Chen, Jie
Wu, Lai-han
Ip, Ying-Chi
Chan, Kelvin Y. K.
Lam, Eric W-F
Khoo, Ui-soon
机构：
[1] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
[2] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, Canc Res UK Labs, London, England
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4724
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway
    Chia-Hung Lin
    Ching-Yao Chang
    Kuan-Rong Lee
    Hui-Ju Lin
    Ter-Hsin Chen
    Lei Wan
    BMC Cancer, 15
  • [22] FoxO3a Mediates the Inhibitory Effects of the Antiepileptic Drug Lamotrigine on Breast Cancer Growth
    Pellegrino, Michele
    Rizza, Pietro
    Nigro, Alessandra
    Ceraldi, Rosangela
    Ricci, Elena
    Perrotta, Ida
    Aquila, Saveria
    Lanzino, Marilena
    Ando, Sebastiano
    Morelli, Catia
    Sisci, Diego
    MOLECULAR CANCER RESEARCH, 2018, 16 (06) : 923 - 934
  • [23] RETRACTED: MiR-155 targeting FoxO3a regulates oral cancer cell proliferation, apoptosis, and DDP resistance through targeting FoxO3a (Retracted Article)
    Li, Xiaoting
    Liu, Kun
    Zhou, Wei
    Jiang, Zhe
    CANCER BIOMARKERS, 2020, 27 (01) : 105 - 111
  • [24] Deregulation of FOXO3A contributes to prostate cancer progression
    Shukla, Sanjeev
    MacLennan, Gregory T.
    Gupta, Sanjay
    JOURNAL OF UROLOGY, 2008, 179 (04): : 460 - 461
  • [25] Deregulation of FOXO3A during prostate cancer progression
    Shukla, Sanjeev
    Shukla, Meenakshi
    MacLennan, Gregory T.
    Fu, Pingfu
    Gupta, Sanjay
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (06) : 1613 - 1620
  • [26] Nuclear p-ser394-FOXO3a/FOXO3a ratio is associated with an improved survival and response to therapy in breast cancer
    Hou, M. F.
    Dai, H. Y.
    Yan, L. Y.
    Yang, S. F.
    Chen, F. M.
    Yeh, Y. T.
    CANCER RESEARCH, 2019, 79 (04)
  • [27] The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells
    Krol, Janna
    Francis, Richard E.
    Albergaria, Andre
    Sunters, Andrew
    Polychronis, Andreas
    Coombes, R. Charles
    Lam, Eric W. -F.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3169 - 3179
  • [28] FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer
    Habashy, Hany Onsy
    Rakha, Emad A.
    Aleskandarany, Mohammed
    Ahmed, Mohamed A. H.
    Green, Andrew R.
    Ellis, Ian O.
    Powe, Desmond G.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) : 11 - 21
  • [29] FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer
    Hany Onsy Habashy
    Emad A. Rakha
    Mohammed Aleskandarany
    Mohamed AH Ahmed
    Andrew R. Green
    Ian O. Ellis
    Desmond G. Powe
    Breast Cancer Research and Treatment, 2011, 129 : 11 - 21
  • [30] CHP2 Promotes Cell Proliferation in Breast Cancer via Suppression of FOXO3a
    Zhao, Xiaohui
    Xie, Tian
    Dai, Ting
    Zhao, Wenhui
    Li, Jing
    Xu, Rui
    Jiang, Chao
    Li, Peiqiong
    Deng, Junyao
    Su, Xiaobo
    Ma, Ningfang
    MOLECULAR CANCER RESEARCH, 2018, 16 (10) : 1512 - 1522
12345